Related Experiment Video
Updated: Mar 1, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Percutaneous Valve Therapy: Choosing the Appropriate Patients and Outcomes
A Sonia Petronio1, Cristina Giannini1
1Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, University of Pisa, via Paradisa n°2, Pisa 46100, Italy.
Abstract:
Surgical aortic valve replacement (SAVR) is the current gold standard for the treatment of severe symptomatic aortic stenosis (AS), but transcatheter aortic valve implantation (TAVI) currently represents a viable alternative to conventional SAVR for patients with AS at high risk of operative mortality. On multivariate analysis it has been shown that female gender is independently associated with better recovery of the left ventricular systolic function after TAVI and that left ventricular hypertrophy reverses more frequently in female patients after SAVR. During follow-up, however, women remain significantly more symptomatic compared with men, mainly because they present with more advanced valve disease at a significantly older age.
Related Concept Videos
Mitral Stenosis III: Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care

